BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25164438)

  • 1. De novo KCNB1 mutations in epileptic encephalopathy.
    Torkamani A; Bersell K; Jorge BS; Bjork RL; Friedman JR; Bloss CS; Cohen J; Gupta S; Naidu S; Vanoye CG; George AL; Kearney JA
    Ann Neurol; 2014 Oct; 76(4):529-540. PubMed ID: 25164438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel epileptic encephalopathy mutation in KCNB1 disrupts Kv2.1 ion selectivity, expression, and localization.
    Thiffault I; Speca DJ; Austin DC; Cobb MM; Eum KS; Safina NP; Grote L; Farrow EG; Miller N; Soden S; Kingsmore SF; Trimmer JS; Saunders CJ; Sack JT
    J Gen Physiol; 2015 Nov; 146(5):399-410. PubMed ID: 26503721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo KCNB1 mutations in infantile epilepsy inhibit repetitive neuronal firing.
    Saitsu H; Akita T; Tohyama J; Goldberg-Stern H; Kobayashi Y; Cohen R; Kato M; Ohba C; Miyatake S; Tsurusaki Y; Nakashima M; Miyake N; Fukuda A; Matsumoto N
    Sci Rep; 2015 Oct; 5():15199. PubMed ID: 26477325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies.
    Veeramah KR; Johnstone L; Karafet TM; Wolf D; Sprissler R; Salogiannis J; Barth-Maron A; Greenberg ME; Stuhlmann T; Weinert S; Jentsch TJ; Pazzi M; Restifo LL; Talwar D; Erickson RP; Hammer MF
    Epilepsia; 2013 Jul; 54(7):1270-81. PubMed ID: 23647072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.
    Bar C; Barcia G; Jennesson M; Le Guyader G; Schneider A; Mignot C; Lesca G; Breuillard D; Montomoli M; Keren B; Doummar D; Billette de Villemeur T; Afenjar A; Marey I; Gerard M; Isnard H; Poisson A; Dupont S; Berquin P; Meyer P; Genevieve D; De Saint Martin A; El Chehadeh S; Chelly J; Guët A; Scalais E; Dorison N; Myers CT; Mefford HC; Howell KB; Marini C; Freeman JL; Nica A; Terrone G; Sekhara T; Lebre AS; Odent S; Sadleir LG; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Hum Mutat; 2020 Jan; 41(1):69-80. PubMed ID: 31513310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel KCNB1 mutation associated with non-syndromic intellectual disability.
    Latypova X; Matsumoto N; Vinceslas-Muller C; Bézieau S; Isidor B; Miyake N
    J Hum Genet; 2017 Apr; 62(5):569-573. PubMed ID: 27928161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel mutation in KCNB1 gene in a child with neuropsychiatric comorbidities with both intellectual disability and epilepsy and review of literature].
    Miao P; Peng J; Chen C; Gai N; Yin F
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):115-119. PubMed ID: 28173649
    [No Abstract]   [Full Text] [Related]  

  • 8. Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant.
    Hawkins NA; Misra SN; Jurado M; Kang SK; Vierra NC; Nguyen K; Wren L; George AL; Trimmer JS; Kearney JA
    Neurobiol Dis; 2021 Jan; 147():105141. PubMed ID: 33132203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
    Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes.
    de Kovel CGF; Syrbe S; Brilstra EH; Verbeek N; Kerr B; Dubbs H; Bayat A; Desai S; Naidu S; Srivastava S; Cagaylan H; Yis U; Saunders C; Rook M; Plugge S; Muhle H; Afawi Z; Klein KM; Jayaraman V; Rajagopalan R; Goldberg E; Marsh E; Kessler S; Bergqvist C; Conlin LK; Krok BL; Thiffault I; Pendziwiat M; Helbig I; Polster T; Borggraefe I; Lemke JR; van den Boogaardt MJ; Møller RS; Koeleman BPC
    JAMA Neurol; 2017 Oct; 74(10):1228-1236. PubMed ID: 28806457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.
    de Kovel CG; Meisler MH; Brilstra EH; van Berkestijn FM; van 't Slot R; van Lieshout S; Nijman IJ; O'Brien JE; Hammer MF; Estacion M; Waxman SG; Dib-Hajj SD; Koeleman BP
    Epilepsy Res; 2014 Nov; 108(9):1511-8. PubMed ID: 25239001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
    Estacion M; O'Brien JE; Conravey A; Hammer MF; Waxman SG; Dib-Hajj SD; Meisler MH
    Neurobiol Dis; 2014 Sep; 69():117-23. PubMed ID: 24874546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of K
    Kang SK; Vanoye CG; Misra SN; Echevarria DM; Calhoun JD; O'Connor JB; Fabre KL; McKnight D; Demmer L; Goldenberg P; Grote LE; Thiffault I; Saunders C; Strauss KA; Torkamani A; van der Smagt J; van Gassen K; Carson RP; Diaz J; Leon E; Jacher JE; Hannibal MC; Litwin J; Friedman NR; Schreiber A; Lynch B; Poduri A; Marsh ED; Goldberg EM; Millichap JJ; George AL; Kearney JA
    Ann Neurol; 2019 Dec; 86(6):899-912. PubMed ID: 31600826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy.
    Rydzanicz M; Zwoliński P; Gasperowicz P; Pollak A; Kostrzewa G; Walczak A; Konarzewska M; Płoski R
    Am J Med Genet A; 2021 Nov; 185(11):3384-3389. PubMed ID: 34448338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
    Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
    Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies.
    Manivannan SN; Roovers J; Smal N; Myers CT; Turkdogan D; Roelens F; Kanca O; Chung HL; Scholz T; Hermann K; Bierhals T; Caglayan HS; Stamberger H; ; Mefford H; de Jonghe P; Yamamoto S; Weckhuysen S; Bellen HJ
    Brain; 2022 Jun; 145(5):1684-1697. PubMed ID: 34788397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo GABRG2 mutations associated with epileptic encephalopathies.
    Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
    Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variability of the clinical expression of KCNB1 encephalopathy].
    Púa-Torrejón RC; González-Alguacil E; Soto-Insuga V; Moreno-Cantero T; Ortiz-Cabrera NV; Pérez-Poyato MS; Ruiz Falcó-Rojas ML; García-Peñas JJ
    Rev Neurol; 2021 Nov; 73(12):403-408. PubMed ID: 34877642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.